期刊文献+

全反式维A酸对单纯疱疹病毒胸苷激酶基因结合更昔洛韦旁观者效应增强作用及其机制 被引量:1

Bystander effect with its mechanism enchanced by all-trans-retinoic acid in herpes simplex virus thynidine kinase gene/ganciclovir system
下载PDF
导出
摘要 目的 通过研究全反式维A酸 (ATRA )对单纯疱疹病毒胸苷激酶基因结合更昔洛韦 (HSV tk/GCV)旁观者效应的增强作用及与Cx4 3表达的关系 ,为提高TK自杀基因的疗效及探索增强作用机制提供实验基础。方法 应用Polybrene转染、荧光定量RT PCR等技术 ,观察ATRA对宫颈癌细胞ME180 ,ME180 /TK转化细胞旁观者效应及诱导Cx4 3mRNA表达的作用。结果 ME180 ,ME180 /TK不同比例的混合细胞随ATRA浓度的增加而存活率降低。ME180 +ME180 /TK混合细胞的存活率随ME180 /TK细胞比例的增加而降低。在 2mg·L- 1更昔洛韦 (GCV)作用下 ,以 10 - 8mol·L- 1ATRA与不加ATRA (0mol·L- 1)的作用相比较 ,在ME180与ME180 /TK不同比例混合的各组中 ,细胞的存活率明显降低 (P <0 .0 5 )。并观察到10 - 8及 10 - 10 mol·L- 1ATRA对GCV旁观者效应的增强作用。RT PCR结果表明 ,经ATRA处理的ME180细胞 ,其Cx4 3mRNA的相对拷贝数比值增高约 1.84倍及 2 .6 5倍。结论 宫颈癌ME180细胞中 ,ATRA在10 - 8~ 10 - 10 mol·L- 1范围内 ,具有明显增强HSV tk/GCV旁观者效应的作用。其主要机制是通过ATRA在转录水平诱导Cx4 3mRNA表达上调 ,导致旁观者效应的增强。 AIM By investigating the bystander effect enchanced by all trans retionic acid (ATRA) in herpes simplex virus thymidine kinase gene/ganciclovir(HSV tK/GCV) system and with relation to Cx43 mRNA expression to provide experimental basis for heightening therapy efficiency of TK suicide gene and exploring mechanism of enchancement role. METHODS Enhancement of the bystander effect in HSV tK/GCV and Cx43 mRNA expression in cervical carcinoma ME180 and ME180/TK transfection cells were examined by using Polybrene transfection, fluor quantitative RT PCR techanques. RESULTS ME180 and ME180/TK mixed cells were suppressed by gradational increase in ATRA concentration in HSV tk/GCV system. The survival rate of ME180+ME180/TK mixed cells decreased with the increase in ME180/TK ratio. In the presence of 2 mg·L -1 GCV, the more lower survival rate was observed at any given mixture of ME180 and ME180/TK cells exposed to 10 -8 mol·L -1 ATRA compared with that in the absence of ATRA (0 mol·L -1 ) (P<0.05). However, enchancement of bystander mediated cell killing occurred only in the concentration range of 10 -8 -10 -10 mol·L -1 of ATRA. The results of RT PCR showed that comparing with non ATRA treated ME180 cells, the ratio of relative copy number of Cx43 mRNA increased by 2.65 and 1.84 fold in ME180 cells exposed to 10 -8 and 10 -10 mol·L -1 ATRA, respectively. CONCLUSION In cervical carcinoma ME180 cell line, ATRA enhances the bystander effect in the HSV tK/GCV system. Its main mechanism of enchancement is up regulation of Cx43 mRNA expression in transcription level.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2003年第6期432-437,共6页 Chinese Journal of Pharmacology and Toxicology
关键词 维A酸 基因 单纯疱疹病毒胸苷激酶/更昔洛韦 旁观者效应 细胞缝隙连接通讯 基因表达 细胞 ME180 tretinoin gene, herpes simplex virus thymidine kinase/ganciclovir bystander effect gap junctional intercellular communication gene expression cell, ME180
  • 相关文献

参考文献1

  • 1Zou ZZ In: Xue QS eds.MTT colorimetry of cellular vitality test[A].In: Xue QS, eds.Principle and Technology of Culture in vitro(体外培养的原理与技术)[C].Beijing: Science Publishing House,2001.343-343.

同被引文献28

  • 1Goins, W. F. Herpes simplex virus vectors for gene transfer to the nervous system[J]. Neurovirol, 1997, 3 (suppl 1): S80-88.
  • 2Glorioso, J.C. Development and application of Herpes virus vectors for Human gene therapy. Annu Rev Micobiol, 1995, 49: 675-710.
  • 3Avner F, Jianjun PT, Giulia F, et al. Glioma Virotherapy: Effects of Innate Immune Suppression and Increased Viral Replication Capacity. Cancer Res, 2006, 66: 2314-2319.
  • 4Rampling R, Cruickshank G, Papanastassiou V. Toxicity evaluation of replication competent herpes simplex virus ( ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma[ J ]. Gene Ther,2000, 7(10): 859-866.
  • 5Markert JM, Medlock MD, Rabkin SD, et al. Conditionally replicaring herpes simplex virus mutant G207 for the treatment of malignant glioma: results of a phase Itrial. Gene Ther, 2000, 7 (10):867-874.
  • 6Papanastassiou V, et al. The potential for efficacy of the modified (ICP 34.5 (-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study. Gene Ther, 2002, 9: 398-406.
  • 7Harland J, Papanastassiou V, Brown SM. HSV1716 persistence in primary human glioma cells in vitro. Gene Ther, 2002, 9:1194 -1198.
  • 8Harrow S, et al. HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival. Gene Ther, 2004, 11 : 1648 - 1658.
  • 9Shah AC, Benos D, Gillespie GY, et al. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J.Neurooncol, 2003, 65: 203 - 226.
  • 10Ozuer A. Effect of genetic background and culture conditions on the production of herpesvirus based gene therapy vectors[J ]. Biotechnol Bioeng, 2002, 77(6): 685-692

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部